Literature DB >> 23158008

[A study on the relationship between single nucleotide polymorphisms of interleukin-22 and susceptibility to pulmonary tuberculosis].

Guang-gui Ding1, Guo-liang Zhang, Xin-chun Chen, Ming-xia Zhang, Lin Yang, Zheng Wang.   

Abstract

OBJECTIVE: To study the association between single nucleotide polymorphisms (SNPs) of interleukin-22 (IL-22) gene and pulmonary tuberculosis.
METHODS: From January 2009 to December 2010, clinical data of 479 patients with pulmonary tuberculosis in Shenzhen Third People's Hospital were collected. There were 212 males, and 267 females, aging from 18 to 69 (mean 36 ± 17) years, as well as 358 healthy controls (162 males and 196 females), aging from 18 to 60 (mean 34 ± 13) years. The genotype of SNPs (rs1182844, rs2227473, rs2227476, rs2227480, rs2227485, rs2227508) in IL-22 gene were determined with MassARRAY assay, after Hardy-Weinberg equilibrium test, and the allelic frequency and odds ratio were calculated. Peripheral blood mononuclear cells (PBMCs) from patients with different rs2227473 genotypes were stimulated with anti-CD3 and CD28, and then the IL-22 concentration in supernatant was determined with ELSIA. The SNP allelic frequencies between 2 groups were analyzed by chi-square and IL-22 concentration by t-test.
RESULTS: The frequency of allele G of rs2227473 SNP was significantly higher in tuberculosis group than that in the control group (χ(2) = 7.448, P < 0.01, OR = 1.509, 95%CI= 1.121 - 2.030). The other 5 SNPs allele frequency were not statistically significant between the 2 groups (χ(2) = 0.528 - 3.571, all P > 0.05). The secretion of IL-22 was significantly lower in PBMCs with genotype GG of rs2227473 SNP as compared to that in the others (GA/AA) (t = 2.686, P < 0.01).
CONCLUSIONS: The results suggested that the rs2227473 SNP in IL-22 was associated with the risk of pulmonary tuberculosis. The allele G was the risk factor of pulmonary tuberculosis. The SNP (rs2227473) may play an important role in the protective immune process against tuberculosis by affecting the IL-22 expression of PBMCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23158008

Source DB:  PubMed          Journal:  Zhonghua Jie He He Hu Xi Za Zhi        ISSN: 1001-0939


  7 in total

1.  Association of interleukin 22 polymorphisms with gastric cancer risk.

Authors:  Shan-yu Qin; Xian-wen Yang; Wei Luo; Mei Chen; Zhi-ling Liu; Si-biao Su; Hai-xing Jiang
Journal:  Tumour Biol       Date:  2014-11-12

2.  Association of interleukin 22 gene polymorphisms and serum IL-22 level with risk of systemic lupus erythematosus in a Chinese population.

Authors:  R Wang; Y-L Zeng; H-M Qin; Y-L Lu; H-T Huang; M Lei; T Tan; Y-Y Huang; H-C Luo; Y Lan; Y-S Wei
Journal:  Clin Exp Immunol       Date:  2018-05-23       Impact factor: 4.330

3.  Lack of association between interleukin-22 gene polymorphisms and cancer risk: a case-control study and a meta-analysis.

Authors:  Huan Wang; Chao Huang; Yuxiao Liu; Puyu Yang; Yuxiao Liao; Xiuli Gu; Xianhong Feng; Bifeng Chen
Journal:  Int J Clin Oncol       Date:  2019-12-12       Impact factor: 3.402

4.  Association of the interleukin-22 genetic polymorphisms with ulcerative colitis.

Authors:  Hong Gang Chi; Xue Bao Zheng; Zhu Guo Wu; Shi Xue Dai; Zheng Wan; Ying Zou
Journal:  Diagn Pathol       Date:  2014-10-09       Impact factor: 2.644

5.  Variants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease.

Authors:  Rong-Hua Song; Qian Li; Wen Wang; Qiu-Ming Yao; Xiao-Qing Shao; Jin-An Zhang
Journal:  Int J Endocrinol       Date:  2017-08-03       Impact factor: 3.257

Review 6.  The Research Progress of Host Genes and Tuberculosis Susceptibility.

Authors:  Li Cai; Zhan Li; Xuhua Guan; Kun Cai; Lei Wang; Jiafa Liu; Yeqing Tong
Journal:  Oxid Med Cell Longev       Date:  2019-08-14       Impact factor: 6.543

7.  Association between interleukin-22 genetic polymorphisms and bladder cancer risk.

Authors:  Tao Zhao; XiaoHou Wu; JiaJi Liu
Journal:  Clinics (Sao Paulo)       Date:  2015-10       Impact factor: 2.365

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.